CTNNA3 and retinal degeneration: Whether in the overall or subgroup analysis (age > 60 years old, smoking, drinking, male, BMI > 24, and no retinal degeneration), CTNNA3-rs7914287 can increase the T2D risk under multiple genetic models among participants.